Halo Healthcare Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Halo Healthcare Inc.
This Month's Profile Group: Medtech Start-Ups Innovate in Urinary Incontinence features profiles of Floelle, InControl Medical, NexHand, and Solace Therapeutics. Plus these Start-Ups Across Health Care: Ablative Solutions, Epiomed Therapeutics, Halo Healthcare, and Thrombolytic Science International.
A women’s health care company in turnaround – one well recognized for assessing a woman’s risk of developing breast cancer through the HALO breast test – is developing a breast cancer diagnostic based on the presence of three protein biomarkers found in breast nipple aspirate fluid. The HALO Pivot diagnostic kit from Halo Healthcare Inc. is an in-office, noninvasive test for diagnosing cancer or a recurrence at a very early stage.
Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including in vitro diagnostics, pharmaceuticals, research/analytical equipment & supplies, and medical devices.
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
- In Vitro Diagnostics
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing